BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26032969)

  • 1. Stability of amoxicillin and amoxicillin/clavulanic acid reconstituted in isotonic saline.
    Carlier M; Verstraete AG; De Waele JJ; Stove V
    J Chemother; 2017 Feb; 29(1):54-56. PubMed ID: 26032969
    [No Abstract]   [Full Text] [Related]  

  • 2. The stability of amoxicillin trihydrate and potassium clavulanate combination in aqueous solutions.
    Jerzsele A; Nagy G
    Acta Vet Hung; 2009 Dec; 57(4):485-93. PubMed ID: 19897453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of amoxicillin and clavulanate degradation alone and in combination in aqueous solution under frozen conditions.
    Vahdat L; Sunderland VB
    Int J Pharm; 2007 Sep; 342(1-2):95-104. PubMed ID: 17592747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of Amoxicillin and Clavulanic Acid in Separate Containers for Administration via a Y-Site.
    Fawaz S; Merzouk M; Barton S; Nabhani-Gebara S
    Drug Des Devel Ther; 2021; 15():3979-3984. PubMed ID: 34584403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of stability indicating HPLC methods for related substances and assay analyses of amoxicillin and potassium clavulanate mixtures.
    Bellur Atici E; Yazar Y; Ağtaş Ç; Ridvanoğlu N; Karlığa B
    J Pharm Biomed Anal; 2017 Mar; 136():1-9. PubMed ID: 28049058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disastrous reflavorig of antibiotics.
    Perrin JH
    Pediatrics; 1997 Sep; 100(3 Pt 1):420. PubMed ID: 9304110
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of potassium clavulanate on the rate of amoxicillin sodium degradation in phosphate and acetate buffers in the liquid state.
    Vahdat L; Sunderland B
    Drug Dev Ind Pharm; 2009 Apr; 35(4):471-9. PubMed ID: 19048426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,3-beta-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid.
    Mennink-Kersten MA; Warris A; Verweij PE
    N Engl J Med; 2006 Jun; 354(26):2834-5. PubMed ID: 16807428
    [No Abstract]   [Full Text] [Related]  

  • 9. A new amoxicillin/clavulanate therapeutic system: preparation, in vitro and pharmacokinetic evaluation.
    Kerč J; Opara J
    Int J Pharm; 2007 Apr; 335(1-2):106-113. PubMed ID: 17141985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid discrimination and determination of antibiotics drugs in plastic syringes using near infrared spectroscopy with chemometric analysis: Application to amoxicillin and penicillin.
    Lê LM; Eveleigh L; Hasnaoui I; Prognon P; Baillet-Guffroy A; Caudron E
    J Pharm Biomed Anal; 2017 May; 138():249-255. PubMed ID: 28231527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and Drug Residue in Eggs After Multiple-Day Oral Dosing of Amoxicillin-Clavulanic Acid in Domestic Chickens.
    Shannon L; Cox SK; Bailey J; Fortner C; Davis R; Gerhardt L; Souza MJ
    J Avian Med Surg; 2020 Mar; 34(1):3-8. PubMed ID: 32237676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microcalorimetric evaluation of the in vitro compatibility of amoxicillin/clavulanic acid and ampicillin/sulbactam with ciprofloxacin.
    Chadha R; Kashid N; Jain DV
    J Pharm Biomed Anal; 2004 Oct; 36(2):295-307. PubMed ID: 15496322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps.
    Binson G; Grignon C; Le Moal G; Lazaro P; Lelong J; Roblot F; Venisse N; Dupuis A
    PLoS One; 2019; 14(8):e0221391. PubMed ID: 31419268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postreconstitution Stability of Amoxicillin-Clavulanic Acid Suspensions at Tropical Room Temperature.
    Maiwada J; Said MM
    J Pediatric Infect Dis Soc; 2019 Sep; 8(4):368-369. PubMed ID: 31329913
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequential injection analysis for the simultaneous determination of clavulanic acid and amoxicillin in pharmaceuticals using second-order calibration.
    Pasamontes A; Callao MP
    Anal Sci; 2006 Jan; 22(1):131-5. PubMed ID: 16429788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients.
    Carlier M; Noë M; De Waele JJ; Stove V; Verstraete AG; Lipman J; Roberts JA
    J Antimicrob Chemother; 2013 Nov; 68(11):2600-8. PubMed ID: 23800901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amoxicillin-clavulanic acid-induced hepatitis.
    Cundiff J; Joe S
    Am J Otolaryngol; 2007; 28(1):28-30. PubMed ID: 17162128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of ampicillin and amoxicillin in peritoneal dialysis solutions.
    Patel RP; Li K; Shastri M; Wanandy T; Jose MD
    Am J Health Syst Pharm; 2015 Jan; 72(1):13-4. PubMed ID: 25511830
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying.
    Weitschies W; Friedrich C; Wedemeyer RS; Schmidtmann M; Kosch O; Kinzig M; Trahms L; Sörgel F; Siegmund W; Horkovics-Kovats S; Schwarz F; Raneburger J; Mönnikes H
    Eur J Pharm Biopharm; 2008 Oct; 70(2):641-8. PubMed ID: 18582572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.